Who owns Enlivex Therapeutics Ltd?
- Ticker: ENLV
- CUSIP Number: m4130y106
Tip: Access positions for across all investors
Analyze quarterly positions in Enlivex Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enlivex Therapeutics stock
Who bought or sold Enlivex Therapeutics Ltd this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 1.7M | $2.4M | 100% | Jun 2024 |
|
| Morgan Stanley | 245k | $348k | 240% | Jun 2024 |
|
| Renaissance Technologies | 75k | $126k | 4% | Sep 2024 |
|
| Citadel Advisors | 24k | $40k | 22% | Sep 2024 |
|
| Goldman Sachs Group | 11k | $16k | 100% | Jun 2024 |
|
| Geode Capital Management | 10k | $18k | 0% | Sep 2024 |
|
| Wells Fargo & Company | 9.2k | $15k | 0% | Sep 2024 |
|
| Group One Trading | 5.7k | $9.6k | 0% | Sep 2024 |
|
| Steward Partners Investment Advisory | 3.0k | $4.3k | 0% | Jun 2024 |
|
| Signature | 3.0k | $5.0k | 100% | Sep 2024 |
|
| Jpmorgan Chase & Co | 1.8k | $3.0k | 685% | Sep 2024 |
|
| Activest Wealth Management | 1.0k | $1.7k | 0% | Sep 2024 |
|
| SRS Capital Advisors | 615.00 | $1.0k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 400.00 | $672.000000 | 0% | Sep 2024 |
|
| Red Tortoise | 150.00 | $252.000000 | 0% | Sep 2024 |
|
| Bank of America Corporation | 145.00 | $244.006000 | 100% | Sep 2024 |
|
| Global Retirement Partners | 11.00 | $18.000400 | 0% | Sep 2024 |
|
| Qube Research & Technologies | 1.00 | $1.000000 | 0% | Jun 2024 |
|
Who sold out of Enlivex Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Jun 2024 | 25k | $35k |